Dr. rer. nat. Silva Holtfreter
Dr. rer. nat. Silva Holtfreter
Phone: +49 3834 86 5518
E-mail: silva.holtfreter[at]uni-greifswald.de
Dr. Silva Holtfreter received her Dipl.-Humanbio. and PhD degrees from the University of Greifswald (Germany) in 2003 and 2009, respectively. After working in the lab of John Fraser at the University of Auckland (New Zealand) for 2.5 years, she moved back to Greifswald in 2012. Since 2016, she is leading a junior research group focusing on immunomics as a tool to improve diagnosis and treatment of infectious endocarditis as well as on passive vaccination with monoclonal antibodies against Staphylococcus aureus (Card-ii-Omics https://www.card-ii-omics.med.uni-rostock.de/).
For more information, please visit Research group Dr. Holtfreter
OUR LATEST RESEARCH
- Frequency of positive anti-PF4/polyanion antibody tests after COVID-19 vaccination with ChAdOx1 nCoV-19 and BNT162b2
T. Thiele et al. Blood 2021
- Discovery of Staphylococcus aureus Adhesion Inhibitors by Automated Imaging and Their Characterization in a Mouse Model of Persistent Nasal Colonization
Liliane M Fernandes de Oliveira et al. Microorganisms 2021
- Allergic Reactions to Serine Protease-Like Proteins of Staphylococcus aureus.
Maria Nordengrün et al. Front Immunol. 2021
- Immune Polarization Potential of the S. aureus Virulence Factors SplB and GlpQ and Modulation by Adjuvants.
Daniel M Mrochen et al. Front Immunol. 2021
- Antibody Production in Murine Polymicrobial Sepsis-Kinetics and Key Players.
Nicolai O et al. Front Immunol. 2020
